News from mimedx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:MDXG)

Feb 11, 2016, 12:11 ET

MiMedx to Present at the RBC Capital Markets' 2016 Global Healthcare conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human...

Feb 10, 2016, 09:00 ET

MiMedx Announces Release Date For 2015 Full Year Results

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human...

Jan 10, 2016, 19:18 ET

MiMedx Exceeds Fourth Quarter And Full Year 2015 Revenue Consensus

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 10, 2016, 19:06 ET

MiMedx Signs Definitive Agreement To Acquire Stability Biologics

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jan 06, 2016, 10:57 ET

MiMedx Receives Certificate From FDA Allowing The Export Of MiMedx Allografts

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 28, 2015, 11:00 ET

MiMedx To Present At 34th Annual J.P. Morgan Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 23, 2015, 12:59 ET

MiMedx Addresses Numerous False Statements in Recent Short Seller Newsletter

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 23, 2015, 11:13 ET

One Hundred patient multi-center Comparative Study of MiMedx Epifix® and Organogenesis Apligraf® is electronically Published

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 16, 2015, 17:00 ET

MiMedx Provides 2016 Guidance With Forecasted Revenue Growth In Excess Of 30% And Operating Earnings Growth Of 80% Or Greater

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 09, 2015, 16:49 ET

MiMedx Announces Release Date For 2016 Outlook And Conference Call

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 07, 2015, 08:30 ET

MiMedx Updates The Status Of Its More Than 5,400 U.S. Hospitals Under Contract

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 03, 2015, 14:28 ET

MiMedx to Present at the Oppenheimer 26th Annual Healthcare Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 01, 2015, 10:04 ET

Coverage For MiMedx Allografts Increases To Over 170 Million Commercial Health Plan Lives

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 20, 2015, 14:53 ET

MiMedx to Present at the Piper Jaffray 27th Annual Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 19, 2015, 18:07 ET

MiMedx Awarded 12 New U.S. Patents YTD 2015 With Four Awarded For Its Amniotic Membrane Allografts And Eight Awarded For Its CollaFix™ Technology

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 16, 2015, 18:24 ET

Sixteen Poster Abstracts Reporting The Clinical Effectiveness And Healing Results Of MiMedx Allografts To Be Presented At Desert Foot Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 12, 2015, 17:10 ET

Latest Peer-Reviewed Clinical Study Confirming The Efficacy And Healing Rates Of MiMedx Allografts Is Published In The Journal Of Wound Care

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 12, 2015, 16:31 ET

Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Is Published In Print Version

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 12, 2015, 14:00 ET

MiMedx To Present At The Canaccord|Genuity Medical Technology And Diagnostics Forum

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 10, 2015, 14:00 ET

MiMedx To Attend The Brean Capital 2015 Life Sciences Summit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...